- Dragan I, Georgiou T, Prodan N, Akolekar R, Nicolaides KH. Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:73-77 pdf
- Andrietti S, Carlucci S, Wright A, Wright D, Nicolaides KH. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in the prediction of preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17403 pdf
- Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17419 pdf
- Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:194-200 pdf
- Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17418 pdf
- Aupont JE, Akolekar R, Illian A, Neonakis S, Nicolaides KH. Prediction of stillbirth by placental growth factor at 19-24 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17229 pdf
- Akolekar R, Machuca M, Mendes M, Paschos V, Nicolaides KH. Placental growth factor in prediction of stillbirths at 11-13 weeks. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17288 pdf
- O' Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, Karagiotis N, Mastrodima S, de Paco Matallana C, Papaioannou G, Pazos A, Plasencia W, Nicolaides KH. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17455 pdf
- Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH. Impaired placentation in women with chronic hypertension that develop preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17517 pdf
- Dragan I, Wright D, Fiolna M, Leipold G, Nicolaides KH. Development of preeclampsia within four weeks of sFLT to PLGF ratio >38: Comparison of performance at 31-34 versus 35-37 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:209-12 pdf
- Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH. Comparison of screening for preeclampsia at 31-34 weeks' gestation by the sFLT to PLGF ratio and a method combining maternal factors with sFLT-1 and PLGF. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17307
- Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound Obstet Gynecol 2017;49:201-8 pdf
- O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17399 pdf
- Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC. A study protocol for the prospective validation study: Screening programme for pre-eclampsia (SPREE). Ultrasound Obstet Gynecol DOI: 10.1002/uog.17467 pdf
- O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open 2016;6:e011801 pdf
- Aupont JE, Akolekar R, Illian A, Neonakis S, Nicolaides KH. Prediction of stillbirth from placental growth factor at 19-24 weeks. Ultrasound Obstet Gynecol 2016;48:631-5 pdf
- Akolekar R, Machuca M, Mendes M, Paschos V, Nicolaides KH. Prediction of stillbirth from placental growth factor at 11-13 weeks. Ultrasound Obstet Gynecol 2016;48:618-23 pdf
- Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2016;48:613-7 pdf
- Frick AP, Syngelaki A, Zheng M, Poon LC, Nicolaides KH. Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of pregnancy. Ultrasound Obstet Gynecol 2016;47:332-9 pdf
- Tsiakkas A, Cazacu R, Wright A, Wright D, Nicolaides KH. Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol 2016;47:472-7 pdf